Rhys John,' Sakinah Othman,2 Arthur B. Parkes,2 John H. Lazarus,2 and ReginaLd Hall2
Interference in Thyroid-Function Tests in Postpartum Thyroiditis
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Three women are described from a study of patients with postpartum thyroiditis whose sera gave spuriously increased concentrations of free thyroid hormone because of antibody binding of radiolabeled thyroxin (T4) and triiodothyronine (T3) analogs. All of the women showed increased serum concentrations of thyroid autoantibodies. The antibody binding of radiolabeled analogs and its effect on free T4 and free T3 assays disappeared by 48 weeks postpartum. Postpartum women who develop thyroid autoantibodies have -2% prevalence of increased binding of radiolabeled analogs, which can result in an interference in thyroid hormone assays involving T4 and T3 analogs. (2) . Spuriously high or low estimates of total thyroid hormone were observed, depending on the method used to separate antibodybound and free hormone concentrations in the RIA technique. The reported prevalence of T4-or T3-binding antibodies varies widely, depending on the patients studied and the methods for detection. Thus, although the interference in total T4 and total T3 RIAs is low (3), the incidence of interference is much higher in assays for free thyroxin (Fr.) and free triiodothyronine (Fr3) involving radiolabeled T4 or T3 analogs. In samples submitted to a routine clinical chemistry department for thyroid-function testing, the incidence of antibody interference in an analog Fr4 assay was 1 in 2460 (4) . We report here the antibody interference we observed in three subjects who were part of a study of postpartum thyroiditis. Interference in an FT3 analog assay has been reported previously in an infant and her mother postpartum (5) , but neither was part of the postpartum study reported here.
Materials and Methods

Subjects
All women who attended the antenatal booking clinic at Caerphilly District Miners' Hospital inMid Glamorgan between October 1987 and January 1990 were screened for the presence of thyroid autoantibodies as previously described (6 (four weeks) 8.0-17.7, (eight weeks) 8.5-18.2, (12 weeks)   8.9-18.6, (16weeks) 9.2-19.0, (20 weeks) 9.5-19.2 radiolabeled PP4 analog, which caused the spuriously high estimate of VP4 at this and subsequent clinic visits (Figure 2 ). An increased result for serum VP3 concentration at 20 weeks postpartum was similarly found to be due toincreased antibody binding of radiolabeled VP3
analog.
An increased concentration of antibody to thyroid microsomes was observed at four weeks postpartum and of antibody to thyroglobulin at eight weeks postpartum. These increased until between 28 and 32 weeks postpartum, and then declined slightly. Paralleling this increase in thyroid antibody concentrations was an increase in the binding of both radiolabeled VP4 and VP3 analog to the patient's serum, which peaked at 20 weeks postpartum and then declined at 48 weeks postpartum.
Patient 3: At 12 weeks postpartum, this patient complained of lack of energy, irritability, intolerance of heat, nervousness, and palpitations. At 40 weeks postpartum, she had lack of energy, a puflr face, dry skin and hair; was intolerant of the cold; and had a poor memory, lack of concentration, and depression. Her mother observed that she was very depressed at 16 weeks postpartum, was easily tired, and lacked concen- tration. She had a small, firm goiter, but was thought to be clinically euthyroid for most of her postpartum period, with only a suspicion of hypothyroidism at 28 and 40 weeks.
Her thyroid-function tests revealed that at eight and 12 weeks postpartum ( Table 1) she became biochemically thyrotoxic, with increased VP4 and VP3 concentrations and decreased TSH concentrations.
By 20 weeks postpartum, she was biochemically hypothyroid with a very low serum Fr4 concentration (5 pmol/L) and a serum TSH concentration >50 milli-int. unitsfL. By 28 weeks postpartum, serum TSH concentration was decreasing and we observed antibody interference in her VP4 measurement at this clinic visit. The data on antibody concentration and binding of radiolabeled T4 and T3 analogs are not complete for this patient because of insufficient serum samples ( Figure   3 ). However, the available data showed an increase in concentration of thyroid microsomal antibody with only a slight increase in concentration of thyroglobulin antibody. At 28 weeks postpartum, we observed increased binding of radiolabeled T4 analog but not of radiolabeledT3 analog.
Discussion
Of the study group of 148 women positive for thyroid antibody, three (2%) developed antibody interference in analog methods for the measurement of VP4 and FT3 during the postpartum period. None of the women negative for thyroid antibody showed any interference in measurements of free thyroid hormone. In all three women studied, thyroid 
